Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-15-000109
Filing Date
2015-12-30
Accepted
2015-12-30 15:43:39
Documents
1
Period of Report
2015-12-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4071
  Complete submission text file 0001250853-15-000109.txt   5643
Mailing Address 181 OAK LANE ROCHESTER NY 14610
Business Address
Henderson Molly (Reporting) CIK: 0001363812 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 151313518

Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)